Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Breakthrough Covid drug for vulnerable proven to save lives - but it's not free on NHS

Research suggests the drug, called Evusheld, would be 88% effective at preventing intensive care admission for people with weakened immune systems still shielding from Covid because vaccines don't work for them.

Daily Mirror

Widening tech, biotech job cuts could jolt broader Bay Area economy: experts

SAN JOSE, Calif. — Bay Area tech and biotech companies have recently revealed plans to chop thousands of jobs, layoffs that raise the specter that these cutbacks might haunt the region’s broader economy.

Tribune News Service

Novavax says Omicron shot shows strong immune response as second booster

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

Psychedelic drug research held back by UK rules and attitudes, say scientists

Active ingredient of magic mushrooms still classified as having no medical value, despite clinical success

The Guardian - UK

Omicron 'grandchildren' mean 300 Covid-19 strains now discovered across the world

The World Health Organisation (WHO) has said these are filling the gaps where Omicron was once rampant

Wales Online

Pandemic greed killed 1.3 million: study

Hoarding vaccines led to 1.3 million unnecessary deaths, while rich countries wasted their shots

Salon

Uganda shortens school term by two weeks to curb Ebola

Uganda will shorten the school term by two weeks to reduce daily contact amongst students and help curb the spread of Ebola, the education minister said on Tuesday.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Calls to expand fifth COVID vaccine rollout as ATAGI considers guidelines

Pressure is mounting on the federal government to expand access to fifth COVID vaccine doses, with a growing number of vulnerable Australians facing waning immunity at a time when case numbers across the country are expected to rise.

ABC News

Needle-free Covid vaccines could be the key to beating the virus

Mucosal vaccines are delivered in your nose or throat, as sniffable or inhalable formulation

Wales Online

Pill to prevent pre-eclampsia gets UK fast track for development

Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition

The Guardian - UK

‘Exciting’ new drug found to reduce blood pressure in patients resistant to treatment

Trial finds drug Baxdrostat to be successful in bringing down blood pressure

Evening Standard

‘Exciting’ development in tackling untreatable high blood pressure

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

The Independent UK

New drug could help tackle 'untreatable' high blood pressure

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Wales Online

Study shows ‘significant drop’ in confidence in vaccines since start of Covid

Scientists warn Covid jab met with ‘particular hostility’ despite evidence of safety

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

StockNews.com

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Radio France Internationale

Uganda still struggling to tackle Ebola as the death toll passes 50

Health authorities in Uganda are struggling to contain the Ebola virus after reporting 51 deaths, including healthcare workers and 132 cases across seven districts in the country. While some government-instituted lockdowns have been put in place, the International Rescue Committee is calling for more funding to curb the spread of…

StockNews.com

3 Biotech Stocks to Accumulate During the Bear Market

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider.

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

Ebola spreads despite lockdown as death toll of killer virus passes 50

Covid-style lockdowns have been extended in Uganda with more than 50 deaths reported since the start of the outbreak.

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

Wales Online

Confidence in vaccines plummets since start of Covid-19 pandemic

The fall is across the board and comes regardless of age, gender, religious belief, education or ethnicity

Daily Mirror

Long Covid sufferers still battling with virus three years on from getting infected

More than two million people in the UK are believed to have Long Covid, with the longest sufferers said to have fallen ill with the virus before the pandemic began

Tribune News Service

Pfizer’s Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long COVID, a study found.

360info

A united front in fight against the 'silent pandemic'

Antimicrobial resistance is one of the biggest public health challenges of our time and we’re at a crossroads on how to combat it.

1 … 106 107 108 109

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.